메뉴 건너뛰기




Volumn 93, Issue 11, 2001, Pages 876-

Re: Re: Role of the insulin-like growth factors in cancer development and progression [1]

Author keywords

[No Author keywords available]

Indexed keywords

RECOMBINANT GROWTH HORMONE; SOMATOMEDIN;

EID: 0035815920     PISSN: 00278874     EISSN: None     Source Type: Journal    
DOI: 10.1093/jnci/93.11.876     Document Type: Letter
Times cited : (2)

References (7)
  • 1
  • 2
    • 0004648857 scopus 로고    scopus 로고
    • U.S. Food and Drug Administration (FDA). FDA responds to citizen petition on BST. FDA Veterinarian Newsletter, No. 3; Available from
    • (2000) , vol.15 , pp. 8
  • 4
    • 0004701355 scopus 로고    scopus 로고
    • Toxicological evaluation of certain veterinary drug residues in food. Fiftieth meeting of the Joint FAO/WHO Expert Committee on Food Additives. Geneva (Switzerland): WHO Food Additives Series. No. 41
    • (1998) , pp. 125-146
    • Ungemach, F.R.1    Weber, N.E.2
  • 6
    • 0032898978 scopus 로고    scopus 로고
    • Transgenic hypersecretion of des(1-3) human insulin-like growth factor I in mouse milk has limited effects on the gastrointestinal tract in suckling pups
    • (1999) J Nutr , vol.129 , pp. 51-56
    • Burrin, D.G.1    Fiorotto, M.L.2    Hadsell, D.L.3
  • 7
    • 0004647997 scopus 로고    scopus 로고
    • Concerning the placing on the market and administration of bovine somatotropin (BST) and repealing Decision 90/218/EC
    • Council decision of 17 December Brussels (Belgium): Eur-Lex; 1999 1999/879/EC
    • (1999) Official Journal of the European Communities.


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.